Marathon Gold 2018 Year in Review and 2019 Plans
Marathon Gold Corporation (“Marathon” or the “Company”) (TSX: MOZ), a growth focused gold exploration and development company, provides a summary of our accomplishments in 2018 and plans for 2019.
Marathon Gold Corporation (“Marathon” or the “Company”) (TSX: MOZ), a growth focused gold exploration and development company, provides a summary of our accomplishments in 2018 and plans for 2019.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company“) and Comstock Metals Ltd. (TSX.V: CSL) (“Comstock” or the “Vendor”) are pleased to announce that they have entered into a binding letter agreement dated January 11, 2019 pursuant to which the Company will purchase from the Vendor the property known as the QV Gold Project (the “Property”) subject to the terms and conditions therein (the “Acquisition”). The Property covers 16,335 hectares (40,000 acres) in the Yukon’s White Gold District, bringing the Company’s total holdings in the White Gold District to 439,000 hectares (1,080,000 acres). The QV Gold Project is contiguous to the Company’s White Gold property which hosts its Golden Saddle and Arc deposits, 20 km southwest of the Company’s Vertigo Discovery on its JP Ross property and 44 kilometres northwest of Goldcorp Inc.’s (TSX: G, NYSE: GG) Coffee project. The Company looks forward to incorporating the Property into its systematic and data driven regional exploration program backed by partners Agnico Eagle Mines Limited (TSX: AEM, NYSE: AEM) and Kinross Gold Corp (TSX: K, NYSE: KGC).
FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) would like to congratulate Cannara Biotech Inc. (“Cannara”) for its listing approval and commencement of trading on the Canadian Securities Exchange (“CSE”) today under the stock symbol “LOVE”. FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares (“Common Shares”) of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer.
Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) is pleased to provide a summary of exploration results from the 2018 exploration program on their 100% owned Justin Gold Project in the Yukon Territory. Work completed in 2018 included the collection of 19 channel and 28 chip samples from 5 trenches, 16 rock samples, 7 till samples and 240 soil samples with coverage totaling 6.0 line-km. The 2018 field program focused primarily on the Lost Ace Zone, a gold bearing zone discovered in 2017. Lost Ace is located 2 kilometers west of Aben’s POW Zone where past drill results indicate potential for bulk-tonnage gold mineralization with intercepts reported ranging from trace values to highs of 1.19 g/t Au over 60.0 m (including 2.47 g/t Au over 21.0 m) and 1.49 g/t Au over 46.4 m.
FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares (“Common Shares“) of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer.
30 day pumping test continuing in CAU07, averaging 647 mg/l lithium
CAU11 pumping test completed averaging 512 mg/l lithium
Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) (Frankfurt: 8N61) (“Triumph Gold” or the “Company”) is pleased to announce the results from two days of prospecting and alteration mapping conducted in July of 2018 on the Andalusite Peak property in north western British Columbia, Canada. Based on positive results from the sampling campaign Triumph Gold increased the Andalusite Peak land package from 9.87 km2 to 31.67 km2 via staking. Highlights of results include:
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company) is pleased to announce Rotary-Air-Blast (“RAB”) drill results from its Betty property located in Yukon, Canada, with numerous drill holes across several target areas encountering near surface gold mineralization. The gold mineralization was encountered along the eastern extension of the Coffee Creek fault which hosts the adjacent Coffee deposit owned by Goldcorp Inc. (TSX: G, NYSE: GG) currently being developed as an open pit and heap leach gold mine with commercial production anticipated to begin in 2021. These results represent a new discovery on a previously undrilled target, discovered through the Company’s systematic and data driven regional exploration program backed by partners Agnico Eagle Mines Limited (TSX: AEM, NYSE: AEM) and Kinross Gold Corp (TSX: K, NYSE: KGC).
FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed cannabis producer under the Cannabis Act, has completed the harvest of its second lot of cannabis and successfully passed all analytical testing, thereby positioning the Company to request a Pre-Sales License Inspection from Health Canada. The Pre-Sales License Inspection is the last step prior to the issuance of a Sales License under the Cannabis Act and Regulations.
Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQB: MLNLF) (“Millennial” or the “Company”) is pleased to provide an update on all its technical programs at its Pastos Grandes Project in Salta, Argentina. The Company is currently engaged in a comprehensive development plan which includes completion of a Definitive Feasibility Study, expansion drilling for an updated resource estimate, operating pilot ponds to provide concentrated lithium-rich brines pumped from the salar, development of a Pilot and Training Lithium Processing Plant designed to produce 3 Tonnes Per Month of Lithium Carbonate Equivalent (LCE), adding additional pumping test wells, and completing various technical studies and infrastructure improvements designed to expedite the Company’s ongoing Feasibility Study.